Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
2-(5-Methyl-1,2,4-oxadiazol-3-yl)propan-2-amine → 6-(3-Chloro-phenyl)-5-cyclopropyl-pyridine-2-carboxylic acid [1-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-ethyl]-amide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 2-(5-Methyl-1,2,4-oxadiazol-3-yl)propan-2-amine | HCID 43559251 | — |
| 반응물 | 6-(3-Chloro-phenyl)-5-cyclopropyl-pyridine-2-carboxylic acid | HCID 71087453 | — |
| 생성물 | 6-(3-Chloro-phenyl)-5-cyclopropyl-pyridine-2-carboxylic acid [1-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-ethyl]-amide | HCID 71093619 | — |
반응 단계
The title compound was synthesized in analogy to Example 1, using 6-(3-chloro-phenyl)-5-cyclopropyl-pyridine-2-carboxylic acid (Example 48 e) and α,α,5-trimethyl-1,2,4-oxadiazole-3-methanamine (CAN 1153831-97-0) as starting materials, MS (EI): m/e=397.1 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09321727B2 |
| 출처 데이터셋 | uspto-grants-2016_04 |
| ORD ID | ord-69310715d85f43ceb38882f543343b8b |
| 출처 메모 | uspto-grants-2016_04 |